NCT00140985View on ClinicalTrials.gov

Antiproteinuric Efficacy of Losartan Potassium in Patients With Non-Diabetic Proteinuric Renal Diseases (0954-213)

PHASE4CompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

February 29, 2000

Primary Completion Date

January 31, 2002

Study Completion Date

January 31, 2002

Conditions
Renal Disorder
Interventions
DRUG

MK0954, losartan potassium/Duration of Treatment: 20 weeks

DRUG

Comparator: amlodipine / Duration of Treatment: 20 weeks

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00140985 - Antiproteinuric Efficacy of Losartan Potassium in Patients With Non-Diabetic Proteinuric Renal Diseases (0954-213) | Biotech Hunter | Biotech Hunter